260 related articles for article (PubMed ID: 24191298)
1. Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes.
Hammerschmidt C; Koenigs A; Siegel C; Hallström T; Skerka C; Wallich R; Zipfel PF; Kraiczy P
Infect Immun; 2014 Jan; 82(1):380-92. PubMed ID: 24191298
[TBL] [Abstract][Full Text] [Related]
2. Elucidating the Immune Evasion Mechanisms of
Walter L; Sürth V; Röttgerding F; Zipfel PF; Fritz-Wolf K; Kraiczy P
Front Immunol; 2019; 10():2722. PubMed ID: 31849943
[No Abstract] [Full Text] [Related]
3. Polymorphic factor H-binding activity of CspA protects Lyme borreliae from the host complement in feeding ticks to facilitate tick-to-host transmission.
Hart T; Nguyen NTT; Nowak NA; Zhang F; Linhardt RJ; Diuk-Wasser M; Ram S; Kraiczy P; Lin YP
PLoS Pathog; 2018 May; 14(5):e1007106. PubMed ID: 29813137
[TBL] [Abstract][Full Text] [Related]
4. CspA from Borrelia burgdorferi inhibits the terminal complement pathway.
Hallström T; Siegel C; Mörgelin M; Kraiczy P; Skerka C; Zipfel PF
mBio; 2013 Aug; 4(4):. PubMed ID: 23943762
[TBL] [Abstract][Full Text] [Related]
5. The OspE-related proteins inhibit complement deposition and enhance serum resistance of Borrelia burgdorferi, the lyme disease spirochete.
Kenedy MR; Akins DR
Infect Immun; 2011 Apr; 79(4):1451-7. PubMed ID: 21282413
[TBL] [Abstract][Full Text] [Related]
6. Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation.
Alitalo A; Meri T; Rämö L; Jokiranta TS; Heikkilä T; Seppälä IJ; Oksi J; Viljanen M; Meri S
Infect Immun; 2001 Jun; 69(6):3685-91. PubMed ID: 11349031
[TBL] [Abstract][Full Text] [Related]
7. Human pathogenic Borrelia spielmanii sp. nov. resists complement-mediated killing by direct binding of immune regulators factor H and factor H-like protein 1.
Herzberger P; Siegel C; Skerka C; Fingerle V; Schulte-Spechtel U; van Dam A; Wilske B; Brade V; Zipfel PF; Wallich R; Kraiczy P
Infect Immun; 2007 Oct; 75(10):4817-25. PubMed ID: 17635869
[TBL] [Abstract][Full Text] [Related]
8. CspA-mediated binding of human factor H inhibits complement deposition and confers serum resistance in Borrelia burgdorferi.
Kenedy MR; Vuppala SR; Siegel C; Kraiczy P; Akins DR
Infect Immun; 2009 Jul; 77(7):2773-82. PubMed ID: 19451251
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional interaction of CihC/FbpC orthologs of relapsing fever spirochetes with host-derived proteins involved in adhesion, fibrinolysis, and complement evasion.
Damm AS; Reyer F; Langhoff L; Lin YP; Falcone FH; Kraiczy P
Front Immunol; 2024; 15():1390468. PubMed ID: 38726006
[TBL] [Abstract][Full Text] [Related]
10. Immune evasion of Borrelia burgdorferi: insufficient killing of the pathogens by complement and antibody.
Kraiczy P; Skerka C; Kirschfink M; Zipfel PF; Brade V
Int J Med Microbiol; 2002 Jun; 291 Suppl 33():141-6. PubMed ID: 12141738
[TBL] [Abstract][Full Text] [Related]
11. Identification and functional characterisation of Complement Regulator Acquiring Surface Protein-1 of serum resistant Borrelia garinii OspA serotype 4.
van Burgel ND; Kraiczy P; Schuijt TJ; Zipfel PF; van Dam AP
BMC Microbiol; 2010 Feb; 10():43. PubMed ID: 20146822
[TBL] [Abstract][Full Text] [Related]
12. The Complement Binding and Inhibitory Protein CbiA of
Nguyen NTT; Röttgerding F; Devraj G; Lin YP; Koenigs A; Kraiczy P
Front Cell Infect Microbiol; 2018; 8():23. PubMed ID: 29456970
[TBL] [Abstract][Full Text] [Related]
13. BBA70 of Borrelia burgdorferi is a novel plasminogen-binding protein.
Koenigs A; Hammerschmidt C; Jutras BL; Pogoryelov D; Barthel D; Skerka C; Kugelstadt D; Wallich R; Stevenson B; Zipfel PF; Kraiczy P
J Biol Chem; 2013 Aug; 288(35):25229-25243. PubMed ID: 23861404
[TBL] [Abstract][Full Text] [Related]
14. Further Insights Into the Interaction of Human and Animal Complement Regulator Factor H With Viable Lyme Disease Spirochetes.
Mühleip JJ; Lin YP; Kraiczy P
Front Vet Sci; 2018; 5():346. PubMed ID: 30766876
[TBL] [Abstract][Full Text] [Related]
15. Inter- and intraspecies-specific adhesion of Lyme borreliae to human keratinocytes.
Bigelmayr S; Koenigs A; Kraiczy P
Ticks Tick Borne Dis; 2019 Jan; 10(1):207-212. PubMed ID: 30391124
[TBL] [Abstract][Full Text] [Related]
16. Delineation of species-specific binding properties of the CspZ protein (BBH06) of Lyme disease spirochetes: evidence for new contributions to the pathogenesis of Borrelia spp.
Rogers EA; Marconi RT
Infect Immun; 2007 Nov; 75(11):5272-81. PubMed ID: 17846117
[TBL] [Abstract][Full Text] [Related]
17. Structural determination of the complement inhibitory domain of Borrelia burgdorferi BBK32 provides insight into classical pathway complement evasion by Lyme disease spirochetes.
Xie J; Zhi H; Garrigues RJ; Keightley A; Garcia BL; Skare JT
PLoS Pathog; 2019 Mar; 15(3):e1007659. PubMed ID: 30897158
[TBL] [Abstract][Full Text] [Related]
18. Borrelia valaisiana resist complement-mediated killing independently of the recruitment of immune regulators and inactivation of complement components.
Schwab J; Hammerschmidt C; Richter D; Skerka C; Matuschka FR; Wallich R; Zipfel PF; Kraiczy P
PLoS One; 2013; 8(1):e53659. PubMed ID: 23320099
[TBL] [Abstract][Full Text] [Related]
19. Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi.
Kraiczy P; Skerka C; Brade V; Zipfel PF
Infect Immun; 2001 Dec; 69(12):7800-9. PubMed ID: 11705962
[TBL] [Abstract][Full Text] [Related]
20. Identification and functional characterization of complement regulator-acquiring surface protein 1 of the Lyme disease spirochetes Borrelia afzelii and Borrelia garinii.
Wallich R; Pattathu J; Kitiratschky V; Brenner C; Zipfel PF; Brade V; Simon MM; Kraiczy P
Infect Immun; 2005 Apr; 73(4):2351-9. PubMed ID: 15784581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
